Home › Cardiomyopathy › Florida
Cardiomyopathy clinical trials in Florida
8 studies for Cardiomyopathy are looking for participants at sites in Florida.
Cities in Florida
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Brandon
- Clinical Trial Site, Miami
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Naples
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07358078Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
- University of South Florida, Tampa
RecruitingPhase 2
Ages 6 and older · All sexes · Updated Sep 2, 2026 · NCT07721025Clinical Course Of Disease In Participants With FA-CM
- University of South Florida, Tampa
RecruitingObservational study
Ages 6 and older · All sexes · Updated Sep 2, 2026 · NCT06865482TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
- University of Florida, Gainesville
- Mayo Clinic in Florida, Jacksonville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT05507879Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Mayo Clinic - Jacksonville, Jacksonville
- University of Miami, Miami
- Cleveland Clinic Florida, Weston
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Danon Disease Natural History Study
- University of Florida College of Medicine, Gainesville
RecruitingObservational study
Ages 8 and older · All sexes · Updated Jul 28, 2026 · NCT06214507MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Mayo Clinic - Jacksonville, Jacksonville
- Cleveland Clinic of Florida, Weston
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.